With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
A mechanism for sharing benefits from the use of DSI, a crucial yet lesser-known aspect of the global biodiversity framework ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback